Advisor Group Holdings, Inc. Acadia Pharmaceuticals Inc Transaction History

Advisor Group Holdings, Inc.

$42.1 Billion
Q1 2025

A detailed history of Advisor Group Holdings, Inc. transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 9,059 shares of ACAD stock, worth $193,319. This represents 0.0% of its overall portfolio holdings.

Number of Shares

9,059

Previous 7,020 29.05%

Holding current value

$193,319

Previous $128,000 17.19%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	BUY	$16.61 - $20.29 $33,867 - $41,371	2,039 Added 29.05%	9,059 $150,000
Q4 2024 Jun 06, 2025	SELL	$14.29 - $18.76 $41,641 - $54,666	-2,914 Reduced 32.17%	6,145 $112,000
Q4 2024 Feb 07, 2025	BUY	$14.29 - $18.76 $1,657 - $2,176	116 Added 1.68%	7,020 $128,000
Q3 2024 Nov 13, 2024	BUY	$15.14 - $19.14 $10,537 - $13,321	696 Added 11.21%	6,904 $106,000
Q2 2024 Aug 13, 2024	SELL	$14.62 - $18.42 $38,231 - $48,168	-2,615 Reduced 29.64%	6,208 $100,000
Q1 2024 May 10, 2024	SELL	$17.79 - $30.86 $361,866 - $627,723	-20,341 Reduced 69.75%	8,823 $163,000
Q4 2023 Feb 12, 2024	SELL	$20.78 - $31.77 $1.48 Million - $2.26 Million	-71,142 Reduced 70.92%	29,164 $913,000
Q3 2023 Nov 13, 2023	BUY	$20.84 - $33.47 $1.43 Million - $2.29 Million	68,397 Added 214.35%	100,306 $2.09 Million
Q2 2023 Aug 10, 2023	BUY	$17.8 - $25.65 $128,765 - $185,552	7,234 Added 29.32%	31,909 $764,000
Q1 2023 May 12, 2023	BUY	$16.32 - $20.92 $43,884 - $56,253	2,689 Added 12.23%	24,675 $464,000
Q4 2022 Feb 10, 2023	SELL	$14.2 - $18.63 $14,171 - $18,592	-998 Reduced 4.34%	21,986 $350,000
Q3 2022 Nov 14, 2022	BUY	$14.11 - $18.27 $1,537 - $1,991	109 Added 0.48%	22,984 $377,000
Q2 2022 Aug 10, 2022	SELL	$13.01 - $27.22 $10,408 - $21,776	-800 Reduced 3.38%	22,875 $322,000
Q1 2022 May 04, 2022	SELL	$20.94 - $27.5 $8,606 - $11,302	-411 Reduced 1.71%	23,675 $482,000
Q3 2021 Nov 05, 2021	SELL	$15.78 - $24.77 $25,137 - $39,458	-1,593 Reduced 6.2%	24,086 $403,000
Q2 2021 Aug 02, 2021	SELL	$19.4 - $27.42 $24,579 - $34,741	-1,267 Reduced 4.7%	25,679 $630,000
Q1 2021 May 13, 2021	SELL	$25.02 - $54.99 $70,206 - $154,301	-2,806 Reduced 9.43%	26,946 $697,000
Q4 2020 Feb 10, 2021	SELL	$41.04 - $56.79 $49,904 - $69,056	-1,216 Reduced 3.93%	29,752 $1.59 Million
Q3 2020 Nov 12, 2020	BUY	$36.42 - $57.0 $240,117 - $375,801	6,593 Added 27.05%	30,968 $1.32 Million
Q2 2020 Aug 14, 2020	BUY	$39.26 - $52.73 $21,396 - $28,737	545 Added 2.29%	24,375 $1.18 Million
Q1 2020 May 18, 2020	BUY	$31.65 - $46.87 $754,219 - $1.12 Million	23,830 New	23,830 $1.01 Million

Others Institutions Holding ACAD

# of Institutions

351

Shares Held

165M

Call Options Held

1.77M

Put Options Held

307K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $3.45B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Account

Advisor Group Holdings, Inc. Acadia Pharmaceuticals Inc Transaction History